Dr Reddy's launches Fexofenadine HCl in US

15 Apr 2011 Evaluate

In a bid to tap $452 million Fexofenadine drug market, Dr Reddy's Laboratories has launched the generic version of Allegra (Fexofenadine HCl) tablets in the US market. The pharmaceutical firm will market the over-the-counter (OTC) product under store brand labels in the US market.  The products are bio equivalent versions of Sanofi-Aventis' Allegra tablets which received Rx-to-OTC switch approval from the FDA on January 24.crackcrack

Dr. Reddys Lab Share Price

1183.00 6.75 (0.57%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...